However, in COVID-19, peptidyl arginine deiminase-4 (PAD4), an enzyme expressed in NETs, changes the structure of ADAMTS-13 and reduces the degrading ability of ADAMTS-13 (60). This evidence concerns the gene ADAMTS13 and COVID-19.